Therefore, efficient removal of oxaliplatin‐induced DNA crosslinks via upregulation of ERCC1 and ERCC4 may therefore represent a survival strategy that could be adopted by ZEB2‐expressing CRC cells to evade cell death. This evidence concerns the gene ERCC1 and colorectal carcinoma.